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Abstract
Background—Early initiation of antiretroviral therapy (ART) has been shown to reduce
mortality among perinatally HIV-infected infants, but availability of virologic testing remains
limited in many settings.
Methods—We collected cross-sectional data from mother-infant pairs in three primary care
clinics in Lusaka, Zambia to develop predictive models for HIV infection among infants age <12
weeks. We evaluated algorithm performance for all possible combinations of selected parameters
using an iterative approach. In primary analysis, we identified the model with the highest
combined sensitivity and specificity.
Results—Between July 2009 and May 2011, 822 eligible HIV-infected mothers and their HIV-
exposed infants were enrolled; of these, 44 (5.4%) infants were diagnosed with HIV. We
evaluated 382,155,260 different parameter combinations for predicting infant HIV infection. The
algorithm with highest combined sensitivity and specificity required 5 of the following 7
parameter thresholds : infant CD8% > 22, infant CD4% ≤ 44, infant weight-for-age Z score ≤ 0,
infant CD4 ≤ 1600 cells/μL, infant CD8 > 2200 cells/μL, maternal CD4 ≤ 600 cells/μL, and
mother not currently on ART for HIV treatment. This combination had a sensitivity of 90.3%,
specificity of 78.4%, positive predictive value (PPV) of 22.4%, negative predictive value (NPV)
of 99.2%, and area under the curve (AUC) of 0.844.
Conclusion—Predicting HIV infection in HIV-exposed infants in this age group is difficult
using clinical and immunologic parameters. Expansion of PCR capacity in resource-limited
settings remains urgently needed.
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Diagnosis of HIV and early initiation of antiretroviral therapy (ART) dramatically improve
survival among infected infants.1 However, as few as 28% of HIV-exposed infants
worldwide undergo HIV testing within the first two months of life.2 The implementation of
early infant diagnosis programs has proven challenging, particularly in high-prevalence,
low-resource settings where the majority of perinatal HIV transmission occurs.3, 4
Definitive diagnosis of HIV in children less than 18 months of age requires virologic assays,
typically polymerase chain reaction (PCR) testing to detect viral DNA or RNA.5-8 Because
infants may retain maternal immunoglobulin-G antibodies for more than a year after birth,
conventional HIV antibody tests have limited utility for accurately determining positive
infection status.9-14 Unfortunately, PCR testing is expensive and, in most developing
countries, available only through specialty laboratories. It is technically complex, requires
staff with special training and technical skill, and can be considerably more costly than other
diagnostic tests.5, 15 Even when access is available, the geographic distances between
clinical facilities and specialty laboratories often result in significant delays in accurate
reporting of results.3, 4 Thus, most countries with large populations of HIV-infected children
have extremely limited capacity for timely infant diagnosis during early infancy.
METHODS
To address this gap in implementation science, we sought to develop a non-virologic
algorithm to predict HIV infection among exposed infants less than12 weeks of age. We
conducted a cross-sectional study across three primary care clinics in Lusaka, Zambia.
Prevention of mother-to-child HIV transmission (PMTCT) services provided by the
Ministry of Health have been previously described.16-18 Briefly, women are offered
“optout” HIV testing at their first antenatal visit. Those identified as HIV-infected are
screened for ART eligibility by clinical staging and CD4 testing. Women meeting criteria
for long-term HIV treatment – CD4 cell counts < 350 cells/μL and/or World Health
Organization (WHO) clinical stage 3 or 4 – are prescribed it immediately. Those who are
not eligible for ART are prescribed short-course zidovudine and peripartum nevirapine. At
the time of study enrollment, the Zambian national PMTCT guidelines had not yet
incorporated maternal or infant antiretroviral prophylaxis during breastfeeding. Following
delivery, infants are scheduled for a six-week postpartum visit, where dried blood spots are
collected for HIV DNA PCR testing.
Cross-sectional data collection
HIV-infected mothers and their infants were recruited from each facility’s maternal and
child health (or “under-5”) department. Candidates were deemed eligible if they met the
following criteria: documented maternal HIV infection, infant age ≤60 weeks, and
willingness to participate in the study. The primary study population comprised infants
under 12 weeks of age; infants age 12 to 60 weeks were separately enrolled to validate the
non-virologic algorithm for older age groups and are not included in this report. Although
maternal and infant antiretroviral drug use for perinatal HIV prophylaxis was permitted, we
excluded infants who had already initiated ART for HIV treatment.
After explaining the study in detail and obtaining written informed consent, we collected
detailed information about the mother and infant, including demographic characteristics,
medical history, physical examination, and laboratory testing. All mothers and infants
underwent WHO staging as part of this study. Weight-for-age Z scores were calculated
using established algorithms from the World Health Organization.19 Maternal tests included
a complete hematologic panel and CD4 count. Infant specimens were drawn for CD4 count
and percentage, CD8 count and percentage, complete hematologic panel, and rapid HIV
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antibody test. Consistent with the standard of care in Zambia at the time, a single HIV DNA
PCR test was performed to determine infant HIV status. All results were reported to
participants at a scheduled visit two to four weeks later. Where appropriate, referrals were
made to an HIV care and treatment department co-located on the same facility grounds.
For the present analysis, we sought to enroll at least 800 HIV-exposed infants under 12
weeks of age and their mothers. This sample size was based on the anticipated precision of
algorithm performance measures. The first 500 enrollees – all from a single clinic – were
included in the “model-building” phase of the study (see below). The remaining enrollees,
approximately 300 mother-infant pairs, provided temporal validation of our initial findings.
Model-building
With data from the first 500 participants, we constructed models to predict infant HIV
infection, defined by a single positive HIV DNA PCR. We first identified maternal and
infant characteristics associated in univariate analysis with infant HIV infection. Those
associations with statistical thresholds of p ≤ 0.01 were included in further analysis. We
used this rigorous threshold for statistical significance to prioritize those with greatest
association to infant HIV infection, while limiting the potential number of variables included
in our final models. For each of these characteristics, we then established pre-defined
increments for assessment, an approach that retained discriminatory power while
minimizing the potential for “over-fitting.”20 We next iteratively dichotomized the
population of interest using multiple cut-off values for each variable. We evaluated all
permutations of factors across all combinations of selected variables. For each combination,
we constructed a two-by-two table that cross-tabulated the algorithm’s categorization of
infants as either HIV-infected or -uninfected, against the gold standard measure of HIV
DNA PCR. The performance for these combinations were then assessed by calculating
sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV),
and area under the receiver operative characteristic curve (AUC). We examined every
increment for each field’s pre-defined range and across every possible number of included
fields.
Selecting and validating predictive models
In our primary analysis, the algorithm with the highest combined sensitivity and specificity
was declared the best-performing, consistent with receiver-operator characteristic
approaches.21, 22 Because AUC can be approximated by adding sensitivity and specificity
and dividing by two,23 this best-performing algorithm prioritized AUC as well. In our
secondary analysis, we sought to maximize sensitivity first, followed by specificity. We
reasoned that such an algorithm could have an important role for triaging HIV-exposed
infants. Those identified as screen-positive could be started on empiric therapy or referred
for further virologic testing. Assuming that the negative predictive value was acceptably
high, those identified as screen-negative could potentially defer virologic testing until after
the cessation of breastfeeding under close clinical monitoring.
We identified the best-performing algorithm for each of these approaches, stratified by the
number of model parameters. These algorithms were temporally validated using our
independently recruited study population of approximately 300 mother-infant pairs, and the
performance measures of sensitivity, specificity, PPV, NPV, and AUC were calculated. All
analyses were performed using SAS version 9.1 (SAS Institute, Cary, NC) and R software
version 2.4.1 (http://www.r-project.org). We obtained ethical review approvals from the
University of North Carolina at Chapel Hill (Chapel Hill, NC, USA), the University of
Alabama at Birmingham (Birmingham, AL, USA) and the University of Zambia (Lusaka,
Zambia).
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Between July 2009 and May 2011, we enrolled 822 eligible HIV-infected mothers and their
HIV-exposed infants under 12 weeks of age. Overall, 44 (5.4%) infants were diagnosed with
HIV by DNA PCR testing. Most participating mothers reported use of PMTCT services
during the antenatal, intrapartum, and postpartum periods. At time of enrollment, the vast
majority of infants (93%) were still exclusively breastfed. Other medical, demographic, and
laboratory characteristics are shown in Table, Supplemental Digital Content 1, http://
links.lww.com/INF/B337. Of these 822 mother-infant pairs, 779 (95%) had complete data
and were included in the model building (n= 481) and validation (n= 298) components of
the study.
We performed univariate analyses to determine predictors for infant HIV infection, using
both maternal and infant parameters (TABLE 1). Seven characteristics met our statistical
threshold for inclusion in the predictive models: infant weight-for-age Z score, infant CD4
count, infant CD8 count, infant CD4 percentage, infant CD8 percentage, maternal CD4
count, and current ART status of the mother. An eighth characteristic, infant CD4:CD8 ratio,
also met the defined statistical threshold but was ultimately excluded because its component
parts were already considered. We used our iterative approach to generate and evaluate
382,155,260 separate models for predicting infant HIV infection within this age group. The
range and parameter thresholds used in constructing these models are shown in Table,
Supplemental Digital Content 2, http://links.lww.com/INF/B338.
In our primary analysis, we sought to maximize the combined value of sensitivity and
specificity. We examined the best-performing algorithms by this standard according to the
number of model parameters (TABLE 2). The highest combined sensitivity and specificity
was observed when any 5 of the following 7 parameter thresholds were met: infant CD8% >
22, infant CD4% ≤ 44, infant weight for age Z score ≤ 0, infant CD4 count ≤ 1600 cells /μL,
infant CD8 count > 2200 cells /μL, maternal CD4 count ≤ 600 cells /μL, and mother not
currently on ART. Overall model performance showed a sensitivity of 90.3% (95%CI:
74.2%-98.0%), specificity of 78.4% (95%CI: 74.4%-82.2%), PPV of 22.4% (95%CI:
15.4%-30.7%), NPV of 99.2% (95%CI: 97.6%-99.8%), and AUC of 0.844 (95%CI: 0.788,
0.900). When we applied this algorithm to our temporal validation cohort, we found that
sensitivity was 41.7% (95%CI: 15.2%-72.3%), specificity was 82.9% (95%CI:
78.0%-87.0%), PPV was 9.3% (95%CI: 3.1%-20.3%), NPV was 97.1% (95%CI:
94.2%-98.8%), and AUC was 0.623 (95%CI: 0.475, 0.770).
For our secondary “triage” model, an algorithm meeting 4 of the following 6 parameter
thresholds performed best: infant CD8% > 22, infant CD4% ≤ 48, infant weight for age Z
score ≤ −0.2, infant CD4 count ≤ 2600 cells /μL, infant CD8 count > 1000 cells /μL, and
mother not currently on ART (TABLE 3). Model performance demonstrated a sensitivity of
100% (95%CI: 88.8%–100%), specificity of 54% (95%CI: 49.3%-58.7%), PPV of 13.0%
(95%CI: 9.0%-18.0%), NPV of 100% (95%CI: 98.5%-100%), and AUC of 0.769 (95%CI:
0.747, 0.793). Validation of the model resulted in a sensitivity of 83.3% (95%CI:
51.6%-97.9%), specificity of 58.4% (95%CI: 52.4%-64.2%), PPV of 7.8% (95%CI:
3.8%-13.8%), NPV of 98.8% (95%CI: 95.8%-99.9%), and AUC of 0.709 (95%CI: 0.595,
0.822).
DISCUSSION
In this study, we evaluated more than 380 million separate cut-point combinations of seven
commonly available parameters to predict HIV infection among infants less than 12 weeks
of age. Our optimal combination demonstrated reasonable performance when compared to
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the gold standard of HIV DNA PCR; however, its sensitivity was not confirmed by temporal
validation. These findings are discouraging and highlight inherent difficulties in diagnosing
infant HIV without virologic testing. By themselves, clinical and immunologic factors are
simply not good enough for use in programmatic settings.
Numerous studies have examined the validity of surrogate markers for predicting HIV
infection among infants. Performance has varied greatly, though certain trends have
emerged. Clinical algorithms, for example, generally demonstrate high specificity at the
expense of sensitivity.24-27 In contrast, laboratory markers such as infant CD4 percentage
show higher sensitivity but lower specificity at studied thresholds.27, 28 Combination
algorithms that include both types of information generally perform better than when either
is considered alone, with sensitivities at 70-90% accompanied by specificities at
40-50%.27, 29 In this context, our best-performing model (sensitivity 90%, specificity 78%)
compared very favorably to other published studies. This study was designed specifically for
the purpose of identifying a non-virologic diagnostic algorithm for HIV infection in infants.
A key strength of our design was the provision made for model validation. We first enrolled
500 mother-infant pairs from a single primary care facility to obtain data from which to
construct our models. We then expanded recruitment to two additional facilities (i.e., three
in total) to test the performance of our best algorithms. In the validation phase, the
performance of our primary algorithm declined considerably. Sensitivity dropped from 90%
to 42%, although specificity remained relatively stable (78% vs. 83%). The smaller
validation sample – along with lower HIV transmission rates – may have contributed to
model instability. With only 13 HIV-infected infants, misclassification of even a single
event could profoundly affect performance. It is also possible, however, that our original
model may have been over-fitted and its findings not applicable across different populations,
even ones that appeared similar. These results emphasize the importance of model validation
as part of algorithm development,20, 30 a process seldom included in analogous studies
seeking to predict infant HIV infection.
In secondary analysis, we considered a predictive algorithm optimized for patient triage. The
best-performing algorithm within these predetermined parameters had 100% sensitivity,
54% specificity, 13% PPV, and 100% NPV. Applied to a hypothetical cohort of 1,000 HIV-
exposed infants and assuming an infant infection rate of 6% (similar to that of this study),
432 could theoretically be triaged from further virologic testing based on a very high
certainty of a negative status. Such a strategy could have important implications for
resource-constrained settings, where HIV DNA PCR testing may be limited by cost or
where geographical distances between the clinic and specialty laboratory may lead to
delayed results reporting. Although sensitivity was reduced in our validation exercise, the
role of triaging algorithms appears promising and should be considered further.
Our study was designed to include both clinical findings and laboratory screening in the
model building process. We emphasized medical information from the infant, though
maternal parameters deemed to be readily available in most clinical settings (e.g., maternal
ART status, maternal CD4) were considered. Interestingly, several infant laboratory tests –
but very few clinical characteristics – were found to be associated with infant infection in
our initial univariate selection of model parameters. Laboratory-intensive algorithms, such
as the ones proposed here, may be constrained by the availability of their component tests.
While we acknowledge this potential limitation, most of our proposed laboratory tests (e.g.,
CD4 testing, hemoglobin) are performed as part of routine HIV care and treatment. Across
the nine provinces in Zambia, for example, the Ministry of Health has certified 161
laboratories with CD4 capacity (personal communication, C. Moyo), in contrast to only
three with HIV DNA PCR testing capacity. CD8 testing, perhaps the one listed assay that is
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not routinely performed, can be conducted on most flow cytometry instruments with only
modest increases in reagent costs.
In the urban Lusaka district, where a robust public sector PMTCT program has been in place
for nearly a decade,16 we observed relatively low HIV transmission rates. Among the 500
infants in the model-building phase, the prevalence of HIV was 6.0%; among the 322 infants
in the validation phase, it was slightly lower at 4.2%. The wide availability of effective
antiretroviral prophylaxis regimens undoubtedly contributed to this success. However, we
also recognize the selection biases inherent to this primary care setting. Since symptomatic
infants are typically referred to the University Teaching Hospital, the country’s only tertiary
care center, this population is underrepresented in our cross-sectional study. Similar work
conducted in settings of higher HIV transmission (e.g., secondary or tertiary care
institutions, rural programs with lower service coverage) could yield different results.
We used an iterative method to determine the optimal thresholds of model parameters to
predict infant HIV infection.31 This technique was computationally intensive, requiring the
generation and evaluation of numerous algorithm combinations. However, this approach has
several advantages over more commonly used techniques such as tree-based recursive
partitioning models. Our methodology permitted optimization of varying performance
measures for different clinical scenarios. We were able to pre-determine clinically relevant
increments and cut-points for our algorithms. Our final algorithm format – which resembles
a checklist rather than the flow charts of tree-based models – may be more clinically
intuitive for frontline providers. In many African countries, initial HIV testing for exposed
infants typically occurs around six weeks of life, a practice recommended by the WHO.32
We restricted our analysis to infants less than 12 weeks of age and, as such, our results are
most applicable to populations infected perinatally or in the early breastfeeding period. We
recognize that these results may not extend to older infants who likely acquire HIV through
breastfeeding. As part of this study, however, we enrolled infants between 12 to 60 weeks to
evaluate predictive models within this older age range. We are planning similar analyses to
determine whether non-virologic algorithms may perform better in this population.
In this study, we sought to address a notable gap in the implementation of comprehensive
pediatric AIDS mitigation programs in Africa: the timely diagnosis of HIV-infected infants
in the months following delivery. Although our analysis yielded promising algorithms for
predicting infant HIV infection, performance did not hold up in validation. We believe a
predictive approach may have utility in settings with limited diagnostic capacity, particularly
in a triaging role. Ultimately, however, PCR – or other molecular technologies that test for
the virus itself – will likely be required. Efforts to increase their access must continue
urgently.
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Refer to Web version on PubMed Central for supplementary material.
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